Skip to content
healthcare.dev

Attruby

NDC 82228-712, acoramidis hydrochloride, tablet, film coated, from BridgeBio Pharma, Inc..

Product NDC
82228-712
Status
Listed
Labeler
BridgeBio Pharma, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216540
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82228-712 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACORAMIDIS HYDROCHLORIDE356 mg/1

Pharmacologic classes

Cytochrome P450 2C9 Inhibitors [MoA]; Transthyretin Stabilizer [EPC]; Transthyretin Stabilizers [MoA]

Package NDCNDC-11Package
82228-712-28822280712284 DOSE PACK in 1 CARTON (82228-712-28) / 1 BLISTER PACK in 1 DOSE PACK / 28 TABLET, FILM COATED in 1 BLISTER PACK
82228-712-30822280712301 BOTTLE in 1 CARTON (82228-712-30) / 120 TABLET, FILM COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/913552ef-875d-4cb7-bf05-a7d20a394c38

Use it

Look up 82228-712 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82228-712 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82228-712. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.